BBNXBeta Bionics, Inc.

BBNX Stock Price, Valuation & Chart | Beta Bionics, Inc.

Compare

$19.070-0.88 (-4.41%)

At close · 01 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Equipment & Services BBNX intrinsic value BBNX calculated fair value vs price

Overview Financials Dividends Ratios

BBNX Historical price chart

BBNX Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization857.95M

PE Ratio-11.56

EPS-1.65

Trading Volume563.31K

Today's High/Low20.09/18.93

Dividend Yield0.00

52 Week High/Low32.71/8.8

Shares Outstanding44.99M

BBNX Financial Statement

BBNX Analyst ratings

BBNX Analysis & performance metrics

BBNX Company profile

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of…

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also…

BBNX Management team

Name

Position

David Henderson

Vice President of Operations

Karen Hynes M.B.A.

Vice President of Marketing

Sean T. Saint PECEO

President, Chief Executive Officer & Director

Mike Mensinger

Chief Product Officer

Steven Russell M.D., Ph.D.

Chief Medical Officer

Blake Beber

Head of Investor Relations

Stephen H. FeiderCFO

Chief Financial Officer, Treasurer & Secretary

Mark Hopman M.B.A., R.Ph.

Chief Commercial Officer

Name

Position

David Henderson

Vice President of Operations

Karen Hynes M.B.A.

Vice President of Marketing

Sean T. Saint PECEO

President, Chief Executive Officer & Director

Mike Mensinger

Chief Product Officer

Steven Russell M.D., Ph.D.

Chief Medical Officer

Blake Beber

Head of Investor Relations

Stephen H. FeiderCFO

Chief Financial Officer, Treasurer & Secretary

Mark Hopman M.B.A., R.Ph.

Chief Commercial Officer

Management Team

David Henderson

Vice President of Operations

Karen Hynes M.B.A.

Vice President of Marketing

Sean T. Saint PECEO

President, Chief Executive Officer & Director

Mike Mensinger

Chief Product Officer

Steven Russell M.D., Ph.D.

Chief Medical Officer

Blake Beber

Head of Investor Relations

Stephen H. FeiderCFO

Chief Financial Officer, Treasurer & Secretary

Mark Hopman M.B.A., R.Ph.

Chief Commercial Officer

Management

David Henderson

Vice President of Operations

Karen Hynes M.B.A.

Vice President of Marketing

Sean T. Saint PECEO

President, Chief Executive Officer & Director

Mike Mensinger

Chief Product Officer

Steven Russell M.D., Ph.D.

Chief Medical Officer

Blake Beber

Head of Investor Relations

Stephen H. FeiderCFO

Chief Financial Officer, Treasurer & Secretary

Mark Hopman M.B.A., R.Ph.

Chief Commercial Officer

Total 8 executives

BBNX Frequently asked questions

What is Beta Bionics, Inc. (BBNX) Stock Price?

Current stock price of Beta Bionics, Inc. (BBNX) stock is $19.070. The stock price is -4.41% lower in the session. The intraday range can be seen from this page. Volume of Beta Bionics, Inc. (BBNX) stock is 563.31K.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Beta Bionics, Inc. (BBNX) stock price going up or down today?

The stock price of Beta Bionics, Inc. (BBNX) can change with earnings, company news, and overall market sentiment. Beta Bionics, Inc. operates in the Healthcare / Medical - Equipment & Services market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Beta Bionics, Inc. stock expensive at its current price?

Whether Beta Bionics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BBNX on this page is -11.56. EPS on this page is -1.65. Compare those figures with peers and growth expectations before deciding if the current Beta Bionics, Inc. price is justified.

How has the stock price of Beta Bionics, Inc. (BBNX) performed historically?

Historical performance for Beta Bionics, Inc. (BBNX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BBNX reacted to past earnings and market events.

Should I buy Beta Bionics, Inc. (BBNX) stock, at this price?

Buying Beta Bionics, Inc. (BBNX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.